A detailed history of Vanguard Group Inc transactions in Nkarta, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,009,940 shares of NKTX stock, worth $7.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,009,940
Previous 2,956,374 1.81%
Holding current value
$7.8 Million
Previous $17.5 Million 22.14%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.52 - $8.0 $242,118 - $428,528
53,566 Added 1.81%
3,009,940 $13.6 Million
Q2 2024

Aug 13, 2024

BUY
$5.27 - $10.82 $5.22 Million - $10.7 Million
990,103 Added 50.35%
2,956,374 $17.5 Million
Q1 2024

May 10, 2024

BUY
$5.59 - $15.71 $2.27 Million - $6.37 Million
405,753 Added 26.0%
1,966,271 $21.3 Million
Q4 2023

Feb 14, 2024

BUY
$1.31 - $6.6 $80,929 - $407,734
61,778 Added 4.12%
1,560,518 $10.3 Million
Q3 2023

Nov 14, 2023

SELL
$1.39 - $2.29 $17,976 - $29,616
-12,933 Reduced 0.86%
1,498,740 $2.08 Million
Q2 2023

Aug 14, 2023

SELL
$2.19 - $5.17 $42,908 - $101,295
-19,593 Reduced 1.28%
1,511,673 $3.31 Million
Q1 2023

May 15, 2023

BUY
$3.37 - $6.3 $400,591 - $748,881
118,870 Added 8.42%
1,531,266 $5.44 Million
Q4 2022

Feb 10, 2023

BUY
$5.14 - $14.35 $274,316 - $765,845
53,369 Added 3.93%
1,412,396 $8.46 Million
Q3 2022

Nov 14, 2022

BUY
$12.27 - $18.39 $318,001 - $476,613
25,917 Added 1.94%
1,359,027 $17.9 Million
Q2 2022

Aug 12, 2022

BUY
$7.77 - $19.44 $5.48 Million - $13.7 Million
705,393 Added 112.37%
1,333,110 $16.4 Million
Q1 2022

May 13, 2022

SELL
$8.66 - $14.99 $2.91 Million - $5.04 Million
-336,372 Reduced 34.89%
627,717 $7.14 Million
Q4 2021

Feb 14, 2022

SELL
$12.79 - $26.88 $2.61 Million - $5.5 Million
-204,435 Reduced 17.5%
964,089 $14.8 Million
Q3 2021

Nov 12, 2021

BUY
$26.67 - $38.76 $958,226 - $1.39 Million
35,929 Added 3.17%
1,168,524 $32.5 Million
Q2 2021

Aug 13, 2021

BUY
$23.94 - $36.68 $27.1 Million - $41.5 Million
1,132,595 New
1,132,595 $35.9 Million

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $126M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.